Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001193125-26-091919·Madryn Asset Management, LP
Schedule 13D ownership disclosure
Neuronetics Inc
Common Stock, par value $0.01 per share · CUSIP: 64131A105
Event date: 2026-03-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- MADRYN ASSET MANAGEMENT, LPReported CIK 0001787423
Shares: 20,737,061 · Class: 30.3%
- MADRYN HEALTH PARTNERS II, LP
Shares: 1,430,953 · Class: 2.1%
- MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP
Shares: 17,044,940 · Class: 24.9%
- MADRYN HEALTH ADVISORS II, LP
Shares: 18,475,893 · Class: 27.0%
- MADRYN HEALTH ADVISORS GP II, LLC
Shares: 18,475,893 · Class: 27.0%
- MADRYN SELECT OPPORTUNITIES, LP
Shares: 2,261,168 · Class: 3.3%
- MADRYN SELECT ADVISORS, LP
Shares: 2,261,168 · Class: 3.3%
- MADRYN SELECT ADVISORS GP, LLC
Shares: 2,261,168 · Class: 3.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-091919
- Form type
- SCHEDULE 13D/A
- Filer
- Madryn Asset Management, LP
- CIK
- CIK 1787423
- Filed
- Mar 04, 2026
- Reporting period
- Mar 02, 2026
- Description
- Schedule 13D beneficial ownership